Welcome to Paid Research Studies




  • Condition:   Alcohol Drinking
    Intervention:   Behavioral: Experimental Mindset Induction
    Sponsor:   University of Konstanz
    Recruiting

  • Conditions:   Intimate Partner Violence;   Domestic Abuse;   Drug and Alcohol Abuse
    Intervention:   Behavioral: Intervention to address family violence and drug and alcohol misuse
    Sponsors:   Australian National University;   University of Peradeniya;   Department of Foregin Affairs and Trade, Australia
    Not yet recruiting

  • Conditions:   Alcohol Dependence;   Alcohol-Related Disorders
    Interventions:   Behavioral: Episodic Future Thinking (EFT);   Behavioral: Episodic Recent Thinking (ERT)
    Sponsor:   Addiction Recovery Research Center
    Recruiting

  • Conditions:   Alcohol Drinking;   Violence
    Interventions:   Behavioral: Step 1 Treatment BI+HC;   Behavioral: Step 1 Treatment BI+TM;   Behavioral: Step 2 Treatment Responders;   Behavioral: Step 2 Treatment Non-Responders
    Sponsors:   University of Michigan;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Consumption, Youth
    Interventions:   Other: Personalized Feedback Intervention with Values;   Other: Personalized Feedback Intervention Traditional
    Sponsor:   Oklahoma State University
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: active approach avoidance training and sham visual probe training;   Behavioral: sham approach avoidance training and active visual probe training;   Behavioral: active approach avoidance training and active visual probe training;   Behavioral: sham approach avoidance training and sham visual probe training
    Sponsors:   University Ghent;   PZ Heilig Hart;   PZ Sint-Camillus;   University of Amsterdam
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Behavioral: Psychoeducational Group Intervention on Alcohol Drinking Related to Stress;   Behavioral: Cognitive Training
    Sponsors:   University of Konstanz;   Centre for Psychiatry Reichenau, Germany
    Recruiting

  • Condition:   Alcohol Disorders
    Intervention:   Other: cognitive remediation
    Sponsor:   University Hospital, Caen
    Not yet recruiting

  • Condition:   Alcohol Drinking in College
    Interventions:   Behavioral: Induction of Implemental Mindset;   Behavioral: Induction of Deliberative Mindset
    Sponsor:   University of Konstanz
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Nicotine Use Disorder
    Intervention:   Behavioral: magnetic resonance imaging (MRI)
    Sponsor:   Oregon Health and Science University
    Not yet recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Mavoglurant;   Drug: Placebo
    Sponsor:   Yale University
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Intoxication;   Alcohol Impairment;   Drive;   Driving Impaired;   Driving Under the Influence;   Behavior, Drinking
    Interventions:   Behavioral: Loss-framed text message;   Behavioral: Gain-Framed text message
    Sponsor:   University of Pennsylvania
    Not yet recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Beer;   Device: Videotaped drinking session
    Sponsor:   University of Florida
    Recruiting

  • Conditions:   Gambling;   Alcohol Consumption
    Interventions:   Behavioral: Gambling Internet Intervention;   Behavioral: Check Your Drinking
    Sponsors:   Centre for Addiction and Mental Health;   University of Calgary;   University of Manitoba
    Not yet recruiting

  • Conditions:   Alcohol and Substance-Related Mental Disorders;   Sexually Transmitted Diseases
    Interventions:   Behavioral: Brief Intervention (BI) with Technology Extender;   Other: Brochure
    Sponsors:   The Miriam Hospital;   Planned Parenthood of Southern New England;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Diabetes;   Endocrine System Diseases;   Gastro-Intestinal Disorder;   Neuro-Degenerative Disease;   Epilepsy;   Autoimmune Diseases;   Renal Disease;   Cardiac Disease;   Metabolic Disease;   Genetic Diseases, Inborn;   Respiratory Disease;   Hematologic Diseases;   Autism Spectrum Disorder;   Fetal Alcohol Spectrum Disorders;   Traumatic Brain Injury;   Stroke
    Interventions:   Other: Patient Navigator;   Other: Usual Care
    Sponsors:   University of Calgary;   Alberta Health Services;   University of Alberta
    Not yet recruiting

  • Condition:   Diabetes Mellitus, Type 1
    Intervention:   Other: Mixed meal with different macronutrient composition
    Sponsors:   Jorge Bondia;   Hospital Francesc de Borja, Gandia, Spain;   Spanish Ministry of Economy, Industry and Competitiveness
    Not yet recruiting

  • Conditions:   Pain;   Alcohol Drinking;   Acute Pain;   Drinking Behavior
    Interventions:   Drug: Low Alcohol;   Drug: Moderate Alcohol;   Drug: Placebo Alcohol;   Other: Pain Induction;   Other: No Pain Induction
    Sponsors:   Syracuse University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Familial Alcoholism Vulnerability
    Interventions:   Drug: Mavoglurant (AFQ056);   Other: Placebo
    Sponsor:   Yale University
    Not yet recruiting

  • Conditions:   Tuberculosis;   HIV/AIDS;   Alcohol Abuse
    Interventions:   Drug: Isoniazid 300 Mg ORAL TABLET;   Drug: Pyridoxine 25 Mg Oral Tablet
    Sponsors:   University of California, San Francisco;   Boston University;   Boston Medical Center;   Mbarara University of Science and Technology
    Recruiting

  • Condition:   Alcohol Drinking
    Intervention:   Other: SSL Implementation Strategy
    Sponsors:   Rhode Island Hospital;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Alcohol (Oral);   Drug: Alcohol (IV);   Drug: Alcohol (Ethanol)
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Suicide, Attempted;   Drug Use;   Alcohol; Use, Problem
    Interventions:   Behavioral: Brief intervention to prevent suicide attempt;   Behavioral: Enhanced treatment as usual
    Sponsors:   University of Rochester;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Alcohol Withdrawal
    Interventions:   Drug: Diazepam 10 MG;   Drug: Baclofen 30mg;   Drug: Baclofen 60mg
    Sponsor:   Universitair Ziekenhuis Brussel
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Depressive Disorder;   Cigarette Smoking
    Intervention:   Device: Intermittent theta burst transcranial magnetic stimulation
    Sponsor:   Stanford University
    Not yet recruiting

  • Condition:   Alcoholic Intoxication
    Interventions:   Device: Active tDCS stimulations;   Device: Sham tDCS
    Sponsor:   Centre Hospitalier Henri Laborit
    Recruiting

  • Conditions:   HIV Infection;   Alcohol Use;   Pain
    Interventions:   Drug: Low dose naltrexone;   Drug: Nalmefene
    Sponsors:   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Generalized Anxiety Disorder;   Panic Disorder;   Social Anxiety;   Alcohol Use Disorder
    Intervention:   Behavioral: Computer-based VC-CBT
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Not yet recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: Self Match;   Behavioral: Ekspert Match
    Sponsor:   Kjeld Andersen
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Lacosamide;   Drug: Placebo oral capsule
    Sponsors:   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Drinking Heavy;   Drinking Behavior;   Drinking Excessive
    Interventions:   Behavioral: Motivational Enhancement Therapy and Strengths Based Case Management (MET/SBCM);   Other: Alcohol education brochure
    Sponsors:   University of California, Los Angeles;   University of California, San Diego;   Providence Health & Services;   Northeastern University
    Not yet recruiting

  • Conditions:   Opioid-use Disorder;   Harmful; Use, Alcohol
    Intervention:   Drug: Nalmefene
    Sponsors:   Yale University;   First Pavlov State Medical University in St. Petersburg, Russia
    Recruiting

  • Conditions:   Major Depression;   Alcohol Use Disorder
    Interventions:   Drug: allogeneic human mesenchymal stem cells (allo-hMSCs);   Drug: Placebo
    Sponsors:   Joshua M Hare;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Liver Diseases, Alcoholic;   Fibrosis
    Interventions:   Diagnostic Test: transient elastography;   Diagnostic Test: Enhanced liver fibrosis test;   Diagnostic Test: Indirect serum markers of liver fibrosis;   Diagnostic Test: Direct serum markers of liver fibrosis;   Diagnostic Test: LiverTRAIL;   Diagnostic Test: Cytokeratin 18;   Diagnostic Test: Omics markers
    Sponsors:   Maja Thiele;   European Commission, H2020;   Novo Nordisk A/S;   University of Southern Denmark;   Esbjerg University Hospital of South-West Jutland;   Odense Municipality Alcohol Rehabilitation Unit;   Svendborg Municipality Alcohol Rehabilitation Unit;   University of Copenhagen;   University of Oslo;   Nordic Bioscience A/S;   VLV Bio, Peviva AB;   Manatee APS;   Siemens Healthcare A/S;   Steno Diabetes Center;   Biomedical Research Foundation, Academy of Athens;   European Molecular Biology Laboratory, EMBL, University of Heidelberg
    Recruiting

  • Conditions:   CRAFT;   Concern Significant Others;   Alcohol Use Disorder
    Intervention:   Behavioral: CRAFT
    Sponsor:   Kjeld Andersen
    Not yet recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Behavioral: Drinking Options - Motivate, Shared Decisions, Telemonitor (DO-MoST)
    Sponsor:   VA Office of Research and Development
    Not yet recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Other: survey
    Sponsor:   Nicole T Shen
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Pregabalin
    Sponsor:   New York State Psychiatric Institute
    Not yet recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Other: Placebo;   Other: Phytocannabinoid cannabidiol (CBD)
    Sponsors:   New York University School of Medicine;   National Institutes of Health (NIH)
    Not yet recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Other: standard therapy
    Sponsor:   Nanfang Hospital of Southern Medical University
    Not yet recruiting

  • Condition:   Binge Drinking, Underage Drinking, Drinking and Driving, Alcohol-Related Harms
    Intervention:   Behavioral: GSDG multi-component intervention
    Sponsor:   HBSA
    Recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: Enhanced Intervention;   Behavioral: Standard Intervention
    Sponsors:   Brown University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Condition:   Alcohol Drinking
    Intervention:   Other: All Participants
    Sponsor:   Butler Hospital
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Post Traumatic Stress Disorder
    Interventions:   Drug: Cannabidiol;   Drug: Placebos
    Sponsors:   New York University School of Medicine;   National Institutes of Health (NIH)
    Not yet recruiting

  • Condition:   Alcohol Intoxication
    Intervention:   Diagnostic Test: LabPatch-alcohol
    Sponsor:   Mclean Hospital
    Not yet recruiting

  • Condition:   Posttraumatic Stress Disorder
    Intervention:  
    Sponsors:   RTI International;   Womack Army Medical Center;   Tripler Army Medical Center;   Landstuhl Regional Medical Center
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   Inflammation;   Neurocognitive Dysfunction;   Craving;   Alcohol Drinking
    Interventions:   Drug: Minocycline;   Drug: Sugar pill
    Sponsors:   University of California, Los Angeles;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Control
    Interventions:   Drug: N-Acetylcysteine;   Drug: Placebo Oral Capsule
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Cocaine Dependence;   Alcohol Dependence
    Interventions:   Device: Real cTBS;   Device: Sham cTBS
    Sponsors:   Medical University of South Carolina;   National Institute on Drug Abuse (NIDA)
    Recruiting

  • Conditions:   Alcohol Dependence, in Remission;   Addiction, Alcohol
    Interventions:   Drug: Exenatide 2 MG Injection;   Drug: BD PosiFlush (saline)
    Sponsors:   Anders Fink-Jensen, MD, DMSci;   The Novavì outpatient clinics, Copenhagen;   Neurobiology Research Unit, Rigshospitalet, Copenhagen;   Section of Biostatistics University of Copenhagen, Copenhagen
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Anxiety Disorders
    Interventions:   Behavioral: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders;   Behavioral: Take Control
    Sponsor:   Boston University Charles River Campus
    Not yet recruiting

  • Condition:   HIV/AIDS
    Intervention:   Behavioral: WELL Program
    Sponsors:   Louisiana State University Health Sciences Center in New Orleans;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Withdrawal Syndrome;   Trauma;   Heavy Drinking;   Alcohol Use Disorder
    Interventions:   Drug: Valproate;   Drug: Lorazepam
    Sponsor:   CAMC Health System
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Alcohol;   Drug: Placebos;   Drug: N-acetyl cysteine
    Sponsors:   William Stoops;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Dietary Supplement: Ketogenic Diet (KD);   Dietary Supplement: Standard American (SA) Meals and Shakes
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Liver Failure;   Liver Diseases, Alcoholic;   Liver Diseases;   Pain, Postoperative;   Transplant; Failure, Liver;   Liver Cirrhosis, Biliary
    Intervention:   Device: BRIDGE device
    Sponsor:   Duke University
    Not yet recruiting

  • Condition:   Substance Abuse
    Intervention:   Behavioral: Coaching
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Bipolar Disorder
    Interventions:   Drug: N-Acetylcysteine;   Drug: Gabapentin;   Drug: Placebo Oral Tablet
    Sponsors:   Medical University of South Carolina;   National Institutes of Health (NIH);   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Binge Drinking;   Unsafe Sex;   HIV/AIDS;   Sexually Transmitted Diseases
    Interventions:   Other: Alcohol Administration;   Other: Placebo Alcohol Administration;   Other: No Alcohol Administration
    Sponsor:   Brown University
    Recruiting

  • Conditions:   Opioid-use Disorder;   Alcohol Use Disorder
    Intervention:   Drug: Gabapentin
    Sponsor:   New York State Psychiatric Institute
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Behavioral: Individualized Assess & Treatment (IATP);   Behavioral: Packaged Cognitive-Behavioral (PCBT);   Behavioral: Case Management (CaseM)
    Sponsors:   UConn Health;   Ronald M. Kadden;   Howard Tennen
    Recruiting

  • Conditions:   Depressive Disorder;   Anxiety Disorder;   Somatoform Disorder;   Alcohol Use Disorder
    Intervention:   Other: collaborative and stepped care model
    Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   Center for Health Care Research Hamburg;   Hamburg Center for Health Economics
    Not yet recruiting

  • Conditions:   Alcohol Abuse;   Post-Traumatic Stress Disorder
    Interventions:   Behavioral: VetChange;   Behavioral: web-based drinking assessment and feedback tool (AFT)
    Sponsor:   Eric Kuhn
    Not yet recruiting

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   Marie-Pierre TAVOLACCI
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Device: Active rTMS;   Device: Sham rTMS
    Sponsor:   VA Office of Research and Development
    Not yet recruiting

  • Conditions:   College Student Drinking;   Eating Disorder;   Stress, Psychological;   Burn Out Syndrome;   Cigarette Smoking;   Hyperactivity;   Health Behavior;   Impulsive Behavior
    Intervention:  
    Sponsor:   Marie-Pierre TAVOLACCI
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Post Traumatic Stress Disorder
    Intervention:   Other: Computerized Plasticity-Based Adaptive Cognitive Training
    Sponsors:   Posit Science Corporation;   VA Palo Alto Health Care System
    Not yet recruiting

  • Condition:   Alcohol Addiction
    Intervention:   Device: Soberlink Cellular Device
    Sponsors:   Soberlink Healthcare LLC;   MAP Health Management LLC
    Recruiting

  • Conditions:   Sexual Assault and Rape;   Risk Behavior;   Alcohol Abuse
    Interventions:   Other: Social Norms Questionnaire;   Other: Standardized Interview;   Other: Group Discussion
    Sponsors:   Womack Army Medical Center;   Rhode Island Hospital;   University of North Carolina, Charlotte
    Recruiting

  • Condition:   ALD - Alcoholic Liver Disease
    Intervention:   Other: Blood draw
    Sponsor:   The Cleveland Clinic
    Recruiting

  • Condition:   PTSD and Alcohol Use Disorder
    Interventions:   Drug: topiramate;   Behavioral: prolonged exposure;   Drug: placebo
    Sponsors:   VA Office of Research and Development;   University of California, San Diego
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Apremilast;   Drug: Placebo
    Sponsors:   The Scripps Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Depression;   Anxiety;   Somatoform Disorders;   Alcohol Abuse
    Intervention:  
    Sponsors:   Charite University, Berlin, Germany;   German Federal Ministry of Education and Research
    Recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Other: Biopsies
    Sponsor:   The Cleveland Clinic
    Recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Other: Alcoholic Beverage;   Other: Non-Alcoholic Beverage;   Drug: Ethanol
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Cardiovascular Diseases;   Diabetes
    Intervention:   Other: Alcohol
    Sponsors:   Beth Israel Deaconess Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Harvard School of Public Health;   Wake Forest University Health Sciences;   Julius Center
    Not yet recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Drug: Bupropion;   Drug: Placebo Oral Tablet
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Substance Abuse;   Risk Reduction;   RIsky Sexual Behavior
    Interventions:   Behavioral: Handbook condition;   Behavioral: Handbook plus condition
    Sponsor:   Washington State University
    Recruiting

  • Condition:   Veisalgia
    Interventions:   Drug: JMI-001;   Drug: Naproxen;   Drug: Fexofenadine;   Drug: placebo
    Sponsor:   JMI Capital Group
    Not yet recruiting

  • Condition:   Hepatic Steatosis
    Intervention:   Drug: VLX103
    Sponsors:   University of Massachusetts, Worcester;   The Cleveland Clinic;   University of Texas Southwestern Medical Center;   University of Louisville
    Recruiting

  • Condition:   Alcoholism
    Intervention:  
    Sponsors:   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institute on Drug Abuse (NIDA);   The Peter G. Dodge Foundation (PGDF)
    Recruiting

  • Condition:   Hepatocellular Carcinoma Non-resectable
    Intervention:   Procedure: Percutaneous ethanol alcohol injection
    Sponsor:   The National Ribat University
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Other: Affective Training;   Other: Neutral Training
    Sponsors:   University of Florida;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Hepatocellular Carcinoma
    Intervention:   Procedure: Combined Treatment
    Sponsor:   The National Ribat University
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: Topiramate and N-Acetyl Cysteine;   Drug: Topiramate and Placebo
    Sponsor:   Nassima Ait-Daoud Tiouririne
    Recruiting

  • Condition:   Cancer
    Intervention:   Behavioral: Tailored knowledge translation
    Sponsors:   McMaster University;   Canadian Institutes of Health Research (CIHR)
    Not yet recruiting

  • Condition:   Alcohol; Harmful Use
    Intervention:   Behavioral: E-alcohol therapy
    Sponsors:   University of Southern Denmark;   TRYG Foundation;   Novavi Outpatient Clinics
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Use Disorder;   Alcohol Abstinence
    Interventions:   Dietary Supplement: kudzu extract, puerarin;   Dietary Supplement: Placebo control
    Sponsor:   Mclean Hospital
    Not yet recruiting

  • Condition:   Psychomotor Impairment
    Interventions:   Drug: delta 9 tetrahydrocannabinol;   Drug: placebo delta 9 tetrahydrocannabinol;   Drug: Alcohol;   Drug: Placebo alcohol
    Sponsors:   Centre for Addiction and Mental Health;   Canadian Institutes of Health Research (CIHR);   Health Canada
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Intervention:   Drug: Methylprednisolone or placebo
    Sponsor:   Erasme University Hospital
    Not yet recruiting

  • Condition:   Alcoholic Hepatitis
    Intervention:   Drug: Combined Vancomycin and Gentamycin and Meropenem
    Sponsor:   University of Aarhus
    Recruiting

  • Conditions:   Smoking;   Heavy Episodic Drinking
    Interventions:   Behavioral: Tobacco Status Project Intervention;   Behavioral: Tobacco Status Project + Alcohol Intervention;   Drug: nicotine patch
    Sponsors:   University of California, San Francisco;   National Institute on Drug Abuse (NIDA)
    Not yet recruiting

  • Conditions:   HBV;   Alcoholic Hepatitis;   Liver Fibroses
    Intervention:   Other: Estimates - prevalence of lifetime/chronic HBV infection
    Sponsors:   University of Alabama at Birmingham;   University Teaching Hospital;   Tropical Gastroenterology and Nutrition Group;   Centre for Infectious Disease Research in Zambia;   Ministry of Health, Zambia
    Recruiting

  • Condition:   Unhealthy Alcohol Use
    Interventions:   Behavioral: Contingency Management Counseling;   Behavioral: Addiction Physician Management;   Behavioral: Motivational Enhancement Therapy
    Sponsors:   Yale University;   VA Connecticut Healthcare System;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Nausea;   Vomiting
    Interventions:   Other: Inhaled Isopropyl Alcohol (IPA);   Drug: Oral Dissolvable Tablet Zofran (ondansetron)
    Sponsor:   Texas Tech University Health Sciences Center, El Paso
    Recruiting

  • Condition:   HIV Infections
    Interventions:   Behavioral: YouTHrive;   Behavioral: Thrive Tips
    Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   University of North Carolina;   University of Michigan;   Emory University;   Children's Hospital of Philadelphia;   Texas Children's Hospital;   Cook County Hospital;   Montefiore Medical Center;   University of South Florida
    Recruiting

  • Condition:   Alcoholic Liver Disease
    Intervention:   Radiation: MRI
    Sponsor:   The Cleveland Clinic
    Recruiting

  • Condition:   Acute Alcohol Intoxication
    Interventions:   Other: Personalized Normative Feedback;   Other: Brief Therapeutic Intervention;   Other: Evaluation questionnaire
    Sponsor:   Rennes University Hospital
    Not yet recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Procedure: Advanced Nurse (AN);   Procedure: General Practitioner (GP)
    Sponsors:   University Hospital, Lille;   Ministry of Health, France
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Anxiety Disorder/Anxiety State;   Stress Disorder;   HPA;   Drinking to Cope
    Intervention:  
    Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Condition:   Alcohol Use
    Interventions:   Drug: Oxytocin;   Drug: Placebo
    Sponsor:   Medical University of South Carolina
    Recruiting

  • Condition:   Alcohol-Related Disorders
    Interventions:   Other: Melatonin;   Other: Placebo
    Sponsor:   Centre for Addiction and Mental Health
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Other: [11C]-(+)-PHNO PET scan;   Other: Alcohol Self-Administration;   Other: Craving Task;   Other: MRI scan;   Other: Neuropsychological Assessment
    Sponsor:   Centre for Addiction and Mental Health
    Recruiting

  • Conditions:   Domestic Violence;   Alcohol Consumption
    Interventions:   Drug: Alcohol beverage;   Drug: Placebo beverage
    Sponsors:   University of New Mexico;   The Mind Research Network
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Varenicline;   Drug: Placebo oral capsule
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Intervention:   Drug: Pioglitazone
    Sponsors:   Emory University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Topiramate;   Drug: placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Smoking Cessation;   Alcohol Drinking
    Interventions:   Drug: Nicotine Replacement Therapy;   Drug: Bupropion;   Behavioral: Cognitive Behavioral Treatment;   Behavioral: Mobile Contingency Management
    Sponsor:   Duke University
    Recruiting

  • Condition:   Antisocial Behavior
    Interventions:   Behavioral: Multisystemic Therapy-Emerging Adults;   Behavioral: Enhanced Treatment as Usual
    Sponsors:   Oregon Social Learning Center;   University of Massachusetts, Worcester
    Recruiting

  • Conditions:   Alcohol Drinking;   Cigarette Smoking Toxicity
    Intervention:   Drug: Reduced nicotine cigarettes
    Sponsor:   Battelle Memorial Institute
    Not yet recruiting

  • Conditions:   Alcohol Drinking;   Marijuana
    Interventions:   Drug: THC 7.2%;   Drug: THC 3.0%;   Drug: Placebo
    Sponsors:   Brown University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Behavioral: Alc-IT (50/50) (morning);   Behavioral: Alc-IT (75/25) (morning);   Behavioral: Control-training (morning);   Behavioral: Alc-IT (50/50) (afternoon);   Behavioral: Alc-IT (75/25) (afternoon);   Behavioral: Control-training (afternoon)
    Sponsors:   University of Bern;   Clinic Südhang;   Forel Clinic
    Recruiting

  • Conditions:   Post Traumatic Stress Disorder (PTSD);   Addiction;   Alcohol Abuse
    Interventions:   Drug: N-Acetylcysteine (NAC) Treatment;   Behavioral: Cognitive Behavioral Therapy;   Drug: Placebo Oral Capsule
    Sponsors:   Medical University of South Carolina;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institutes of Health (NIH)
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Saracatinib;   Drug: Placebos
    Sponsor:   Yale University
    Recruiting

  • Condition:   Mild to Heavy Alcohol Consumption
    Intervention:   Other: Oxycodone
    Sponsors:   University of Washington;   National Institutes of Health (NIH);   National Institute on Aging (NIA);   Seattle Institute for Biomedical and Clinical Research
    Recruiting

  • Conditions:   HIV Positive;   Alcohol Use
    Interventions:   Behavioral: Computerized Brief Intervention (CBI);   Behavioral: CBT4CBT;   Drug: Recommendation and Counseling for Alcohol Pharmacotherapy
    Sponsor:   University of Alabama at Birmingham
    Not yet recruiting

  • Conditions:   Alcohol Use Disorder;   PTSD;   Cognitive Dysfunction
    Interventions:   Behavioral: Cognitive Training;   Behavioral: Cognitive training placebo control
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   HIV;   Partner Violence;   Malnutrition;   Alcohol Use/Abuse;   Depression
    Interventions:   Behavioral: Accountable Condition;   Behavioral: Control Condition
    Sponsors:   University of California, Los Angeles;   National Institute of Mental Health (NIMH);   University of Stellenbosch
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: standard medical therapy;   Drug: G-CSF;   Drug: n-Acetylcysteine
    Sponsor:   Postgraduate Institute of Medical Education and Research
    Recruiting

  • Conditions:   Self-regulation;   Adolescents;   Fetal Alcohol Spectrum Disorder
    Intervention:   Behavioral: Self-Regulation Intervention adapted from the Alert Program ®
    Sponsors:   University of Alberta;   Glenrose Rehabilitation Hospital;   Woman and Children's Health Research Institute;   NeuroDevNet;   Provincial Health Services Authority;   University of British Columbia
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Zonisamide;   Behavioral: Take Control;   Drug: Placebo (for Zonisamide)
    Sponsors:   Boston University Charles River Campus;   Mclean Hospital;   University of Houston
    Not yet recruiting

  • Conditions:   Alcoholism;   Substance-Related Disorders
    Interventions:   Drug: intranasal oxytocin spray;   Other: intranasal spray without oxytocin
    Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Lade Addiction Treatment Center
    Recruiting

  • Conditions:   HIV;   Alcohol Use Disorders
    Intervention:   Other: Transitional HIV care for prison releasees
    Sponsors:   University of North Carolina, Chapel Hill;   National Institutes of Health (NIH);   John E. Fogarty International Center (FIC)
    Recruiting

  • Conditions:   Posttraumatic Stress Disorder (PTSD);   Alcohol Use Disorder (AUD);   Substance Use Disorder (SUD)
    Interventions:   Drug: N-acetylcysteine;   Drug: Placebo;   Behavioral: Cognitive behavioral therapy
    Sponsors:   Medical University of South Carolina;   United States Department of Defense;   Institute for Translational Neuroscience
    Recruiting

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   University Hospital, Lille
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Device: MRI: Brain Imaging data collection
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting

  • Conditions:   PTSD;   Alcohol Use Disorder
    Interventions:   Drug: Pregabalin plus BBCET;   Other: Placebo plus BBCET
    Sponsors:   University of Maryland;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Smoking Cessation;   Alcohol Drinking
    Interventions:   Drug: Chantix;   Behavioral: Behavioral Counseling Sessions;   Drug: NicodermCQ
    Sponsors:   University of Chicago;   Pfizer
    Not yet recruiting

  • Conditions:   Tuberculosis;   Alcohol Consumption;   Treatment Adverse Effect
    Intervention:   Behavioral: DOTS Adherence Monitoring
    Sponsors:   Boston Medical Center;   Medical Research Council, South Africa;   Boston University;   University of Cape Town;   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting

  • Conditions:   Alcohol Drinking;   Alcohol Drinking Related Problems
    Interventions:   Behavioral: Retrieval-extinction;   Behavioral: Extinction;   Behavioral: Retrieval
    Sponsor:   National Institute on Drug Abuse (NIDA)
    Recruiting

  • Condition:   Alcohol Use
    Intervention:   Behavioral: Brief Negotiational Intervention
    Sponsors:   Duke University;   Kilimanjaro Christian Medical Centre, Tanzania;   John E. Fogarty International Center (FIC)
    Not yet recruiting

  • Condition:   Alcohol Withdrawal
    Interventions:   Drug: Ketamine;   Drug: Dexmedetomidine;   Drug: Normal saline
    Sponsor:   University of Colorado, Denver
    Not yet recruiting

  • Conditions:   Attention Deficit Hyperactivity Disorder;   Alcohol-Related Disorders;   Substance-Related Disorders
    Interventions:   Behavioral: SUCCEEDS Program;   Behavioral: Living a Healthy College Lifestyle
    Sponsors:   University of Maryland;   University of Memphis
    Recruiting

  • Condition:   Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders
    Intervention:   Behavioral: VBMI
    Sponsors:   G.V. (Sonny) Montgomery VA Medical Center;   Merck Sharp & Dohme Corp.
    Recruiting

  • Conditions:   Posttraumatic Stress Disorder;   Alcohol Use Disorders
    Intervention:   Behavioral: Brief Cognitive Therapy
    Sponsors:   University of Washington;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Drinking Behavior;   Risky Drinking
    Interventions:   Behavioral: SMI + I;   Behavioral: SMI
    Sponsors:   University of Michigan;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholic Hepatitis (AH)
    Interventions:   Drug: Selonsertib;   Drug: Prednisolone;   Drug: Placebo
    Sponsor:   Gilead Sciences
    Recruiting

  • Conditions:   HIV Infection;   Alcohol Use;   Smoking
    Interventions:   Drug: Varenicline;   Drug: Cytisine;   Drug: Nicotine Replacement Therapy;   Drug: Varenicline Placebo;   Drug: Cytisine Placebo;   Drug: Nicotine Replacement Therapy Placebo
    Sponsors:   Boston Medical Center;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Traumatic Brain Injury (TBI);   Hazardous and Harmful Alcohol Use
    Interventions:   Behavioral: Medical Management Counseling;   Drug: N-acetylcysteine;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   United States Department of Defense;   Northern California Institute of Research and Education;   San Francisco Veterans Affairs Medical Center;   Institute for Translational Neuroscience
    Recruiting

  • Condition:   Obesity
    Interventions:   Other: Oral Alcohol challenge test Alcohol visit first;   Other: Oral Alcohol challenge test Placebo visit first;   Other: Intravenous Alcohol Challenge Test (Clamp);   Other: Intravenous Alcohol Self-administration Test
    Sponsors:   University of Illinois at Urbana-Champaign;   Carle Foundation Hospital
    Recruiting

  • Condition:   Wernicke-Korsakoff Syndrome
    Intervention:   Drug: Thiamine Hydrochloride
    Sponsor:   Menzies School of Health Research
    Recruiting

  • Condition:   HIV Infection
    Interventions:   Drug: ART initiation at time of HIV diagnosis;   Drug: ART at 24 weeks
    Sponsors:   Fred Hutchinson Cancer Research Center;   University of California, San Francisco;   University of Washington;   Asociación Civil Impacta Salud y Educación, Peru;   Université de Montréal;   Seattle Children's Hospital
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Disulfiram
    Sponsor:   New York State Psychiatric Institute
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: Standard of care + pegfiltrastim;   Drug: Standard of care
    Sponsors:   Timothy Morgan, MD;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: Oxytocin;   Other: Placebo
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Not yet recruiting

  • Conditions:   Pain;   Opiates;   Alcohol Drinking
    Interventions:   Behavioral: Prevention Intervention;   Behavioral: Brief Intervention
    Sponsors:   University of Pennsylvania;   United States Department of Defense;   Corporal Michael J. Crescenz VA Medical Center;   Medical University of South Carolina;   VA Pittsburgh Healthcare System
    Recruiting

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active inhaled delta-9-THC;   Drug: Placebo;   Drug: Active Oral Ethanol
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active Dronabinol;   Drug: Placebo;   Drug: Active Ethanol
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Obesity;   Smoking Cessation;   Alcoholism
    Interventions:   Drug: Exenatide;   Biological: Desacyl ghrelin;   Biological: Saline
    Sponsor:   Imperial College London
    Recruiting

  • Condition:   Alcohol Abuse
    Interventions:   Behavioral: ACHESS;   Behavioral: TMC
    Sponsor:   University of Pennsylvania
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: PF-05190457;   Behavioral: MI-VF;   Other: Placebo;   Other: Counseling
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Use Disorder Cognitive Decline
    Intervention:   Behavioral: Cognitive Remediation Training
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Alcohol Consumption
    Interventions:   Drug: Placebo;   Drug: 10 mg Obeticholic Acid (OCA)
    Sponsors:   Suthat Liangpunsakul;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Intercept Pharmaceuticals
    Recruiting

  • Conditions:   Cardiovascular Disease (CVD);   Hypertension;   Hyperlipemia;   Obesity
    Intervention:   Other: Community-based peer health coach intervention
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Healthy Controls;   Alcohol Use Disorder
    Interventions:   Drug: Placebo;   Drug: Oxytocin
    Sponsor:   University of Utah
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Nalmefene;   Other: Placebo
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Coronary; Ischemic;   Arrhythmias, Cardiac;   Heart Failure;   Peripheral Vascular Diseases;   Dementia;   Stroke;   Pulmonary Disease, Chronic Obstructive;   Respiratory Insufficiency;   Alcoholism;   Cancer;   Diabetes;   Renal Insufficiency
    Interventions:   Procedure: OPTI-AGED;   Procedure: Usual Care
    Sponsor:   Centre Hospitalier Universitaire de Saint Etienne
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Device: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 1;   Device: Multi-method Neuroendocrine and Neuroimaging Procedure Scan 2
    Sponsor:   Yale University
    Recruiting

  • Condition:   Alcohol Use Disorder
    Intervention:   Drug: Baclofen
    Sponsors:   University Hospital, Lille;   Région Nord-Pas de Calais, France;   Groupement Interrégional de Recherche Clinique et d'Innovation
    Recruiting

  • Condition:   Acute Alcoholic Hepatitis
    Interventions:   Biological: ELAD System;   Other: Standard of Care (Control)
    Sponsor:   Vital Therapies, Inc.
    Recruiting

  • Conditions:   Alcohol Consumption;   HIV;   Motivation
    Interventions:   Behavioral: Motivational Interviewing;   Other: Questionnaire assessment;   Other: Neurocognitive assessments;   Other: Blood specimens
    Sponsors:   University of Florida;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Dependence
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Substance Use Disorder
    Interventions:   Behavioral: Resonance Breathing;   Behavioral: Non-Resonance Breathing
    Sponsors:   Rutgers, The State University of New Jersey;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol-Related Disorders;   Alcohol Use Disorders;   Alcohol Drinking;   Alcoholism;   Alcohol Abuse
    Interventions:   Behavioral: Brief Advice;   Behavioral: Motivational Interviewing;   Behavioral: Behavioral Self-Control Training
    Sponsors:   Northwell Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Posttraumatic Stress Disorder;   Alcohol Use Disorders
    Interventions:   Drug: doxazosin;   Drug: placebo
    Sponsors:   VA Office of Research and Development;   Medical University of South Carolina;   Consortium to Alleviate PTSD
    Recruiting

  • Conditions:   Alcohol Use;   Drug Use;   Diagnostic Self Evaluation;   Gonorrhea;   Unprotected Sex;   Chlamydia;   Trichomonas
    Interventions:   Behavioral: Project EMPWR;   Other: Optimized Standard Care (OSC)
    Sponsor:   Johns Hopkins Bloomberg School of Public Health
    Recruiting

  • Conditions:   Major Depressive Disorder;   Alcohol Use Disorder
    Interventions:   Drug: Ketamine + Naltrexone;   Drug: Ketamine + Placebo;   Drug: Placebo (psychoactive placebo midazolam) + Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Bipolar Disorder;   Anxious Disorder;   Alcohol Dependence
    Interventions:   Behavioral: Cognitive and Behavior Therapy (CBT);   Behavioral: Mindfulness Based Cognitive Therapy (MBCT)
    Sponsor:   Centre Hospitalier St Anne
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Use Disorder
    Intervention:   Drug: XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
    Sponsors:   New York University School of Medicine;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Abuse
    Intervention:   Behavioral: Youth Access
    Sponsor:   Oregon Research Institute
    Recruiting

  • Conditions:   Fear;   Stress;   Alcohol Dependence
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Suicide;   Alcohol Drinking
    Intervention:   Behavioral: motivational enhancement therapy
    Sponsors:   Boston Children’s Hospital;   American Foundation for Suicide Prevention
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Interventions:   Drug: Bovine Colostrum;   Drug: Placebo
    Sponsor:   Dayanand Medical College and Hospital
    Not yet recruiting

  • Condition:   Alcoholism
    Interventions:   Behavioral: Motivational Enhancement Therapy;   Behavioral: Cognitive Behavioral Therapy;   Other: FC Assessment;   Other: IB Assessment
    Sponsors:   Rutgers, The State University of New Jersey;   Syracuse University;   Pacific Institute for Research and Evaluation;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Cannabis;   Alcohol Effect;   Driving Under the Influence of Alcohol and Other Drugs
    Interventions:   Drug: Active delta-9-THC;   Drug: Placebo;   Drug: Active Ethanol
    Sponsor:   Yale University
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Zonisamide;   Drug: Placebo
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Alcoholism;   Attention Deficit Disorder With Hyperactivity
    Intervention:   Behavioral: cognitive and psychiatric assessment
    Sponsors:   University Hospital, Lille;   Institute for Scientific Research on Beverages (France)
    Recruiting

  • Condition:   Alcohol Use Disorder
    Interventions:   Drug: Ondansetron;   Drug: Placebo
    Sponsors:   University of Maryland;   University of Pennsylvania
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Drug: Topiramate;   Behavioral: Medical Management;   Drug: Inactive Placebo
    Sponsors:   University of Pennsylvania;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institutes of Health (NIH);   Department of Health and Human Services;   Corporal Michael J. Crescenz VA Medical Center
    Recruiting

  • Condition:   Alcohol Dependence
    Intervention:   Other: Alcohol administration
    Sponsor:   University of Maryland
    Recruiting

  • Conditions:   Substance-Related Disorders;   Human Immunodeficiency Virus;   Alcoholism
    Interventions:   Behavioral: Soccer League (SL);   Behavioral: Soccer League/Vocational Training (SL-V)
    Sponsors:   University of California, Los Angeles;   National Institute on Drug Abuse (NIDA)
    Recruiting

  • Condition:   Alcoholism
    Intervention:   Behavioral: Cognitive Behavioral Coping Skills Therapy
    Sponsor:   New York State Psychiatric Institute
    Recruiting

  • Conditions:   HIV;   Hepatitis C
    Interventions:   Behavioral: Motivational Interviewing;   Behavioral: Brief Advice
    Sponsor:   Butler Hospital
    Recruiting

  • Conditions:   Human Immunodeficiency Virus;   HBV;   Fibrosis, Liver;   Cirrhosis, Liver;   Hepatocellular Carcinoma;   Hepatitis Delta Virus;   Alcoholic Hepatitis
    Intervention:   Drug: Anti-HIV Agents
    Sponsors:   University of Alabama at Birmingham;   John E. Fogarty International Center (FIC);   National Institutes of Health (NIH)
    Recruiting

  • Condition:   Alcohol Use Disorders
    Intervention:   Behavioral: Cue Exposure Treatment
    Sponsor:   University of Southern Denmark
    Recruiting

  • Conditions:   Infection;   Alcohol Abuse;   Drugs of Abuse;   Lung Injury
    Intervention:   Other: Characterize alcohol and drug use
    Sponsors:   University of Colorado, Denver;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Risk Reduction Behavior
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Alcohol Use Disorders
    Interventions:   Behavioral: Intensive Motivational Interviewing;   Behavioral: Single session of Motivational Interviewing
    Sponsor:   Public Health Institute, California
    Recruiting

  • Condition:   Hepatitis
    Intervention:  
    Sponsor:   Basildon and Thurrock University Hospitals NHS Foundation Trust
    Recruiting

  • Conditions:   Alcoholic Hepatitis;   Alcoholic Liver Disease
    Interventions:   Drug: Amoxicillin;   Drug: Placebo;   Drug: Prednisolone
    Sponsors:   University Hospital, Lille;   Ministry of Health, France
    Recruiting

  • Conditions:   Alcohol Use Disorders;   Stress Disorders, Posttraumatic;   Combat Disorders
    Interventions:   Drug: prazosin hydrochloride;   Drug: placebo
    Sponsors:   Seattle Institute for Biomedical and Clinical Research;   United States Department of Defense;   VA Puget Sound Health Care System
    Recruiting

  • Conditions:   AOD Use, Abuse, and Dependence;   Depression
    Interventions:   Behavioral: MET/CBT-12;   Behavioral: CBT-D;   Other: D-TAU
    Sponsors:   Duke University;   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcoholism
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcoholism;   Substance-related Disorders;   Dual Diagnosis
    Interventions:   Behavioral: Group Motivational Interviewing (GMI);   Behavioral: Control Treatment Condition (CT)
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Condition:   Alcoholism
    Interventions:   Device: MRI;   Drug: C-11PBR28;   Drug: F-18FDG
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Minocycline;   Drug: Placebo (for Minocycline)
    Sponsors:   Yale University;   United States Department of Defense
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Use Disorders;   Alcohol Abuse;   Alcoholism
    Interventions:   Drug: Mifepristone 1200 mg daily;   Behavioral: Standardized behavioral therapy;   Drug: Mifepristone 600 mg daily;   Drug: Placebo
    Sponsors:   The Scripps Research Institute;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Eligible to go Into the MRI Scanner;   Short-term Abstinence From Alcohol Use (2 Week Abstinent)
    Intervention:   Device: Transcranial Direct Current Stimulation (tDCS)
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Guanfacine 3mg/day;   Drug: Guanfacine 1.5mg/day;   Drug: Placebo
    Sponsors:   Yale University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Obesity
    Intervention:  
    Sponsor:   University of Missouri-Columbia
    Recruiting

  • Conditions:   Alcohol Use Disorder;   Contingency Management
    Interventions:   Behavioral: Prize Contingency Management for Alcohol Abstinence;   Behavioral: Standard Care
    Sponsors:   UConn Health;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Magnetic Resonance Imaging;   Major Depression;   Alcoholism
    Interventions:   Drug: Ketamine;   Other: Alcohol Infusion
    Sponsor:   National Institute of Mental Health (NIMH)
    Recruiting

  • Conditions:   Evaluating NIAAA's Alcohol Screener;   Evaluating a Brief Intervention
    Interventions:   Behavioral: Brief Intervention;   Behavioral: Brief Intervention with Coaching;   Behavioral: Treatment as Usual
    Sponsors:   University of Rhode Island;   Brown University
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Drinking;   Alcoholism
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcohol Dependence;   Alcohol Drinking;   Alcohol-Related Disorders;   Alcoholism;   Brain Mapping
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Conditions:   Alcoholism;   fMRI;   Rewarding Mediating System
    Intervention:  
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting

  • Condition:   Alcohol Drinking
    Interventions:   Drug: Topiramate;   Drug: Placebo
    Sponsor:   University of Pennsylvania
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: Psilocybin;   Drug: Diphenhydramine;   Behavioral: Motivational Enhancement and Taking Action (META)
    Sponsors:   New York University School of Medicine;   Heffter Research Institute;   University of New Mexico
    Recruiting

  • Condition:   Alcoholic Hepatitis
    Intervention:  
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   University of Wisconsin, Madison;   King's College London;   Veterans Medical Research Foundation;   Universidad Autonoma de Nuevo Leon;   Hospital Vall d'Hebron
    Recruiting

  • Conditions:   Unhealthy Alcohol Use;   Alcohol Use Disorder;   Alcohol Disorders
    Intervention:   Behavioral: Relational Agent Intervention
    Sponsors:   VA Office of Research and Development;   Northeastern University;   Boston University
    Recruiting

  • Conditions:   Atrial Fibrillation;   Alcohol
    Interventions:   Drug: Ethanol;   Drug: Placebo
    Sponsor:   University of California, San Francisco
    Recruiting

  • Conditions:   Alcohol Use;   AA Attendance;   Sexual Risk Behavior
    Intervention:   Other: Introduction to AA volunteer
    Sponsor:   Butler Hospital
    Recruiting

  • Condition:   Hepatitis, Alcoholic
    Interventions:   Drug: IMM 124-E (Hyperimmune Bovine Colostrum);   Drug: Placebo (High protein milk powder)
    Sponsors:   Virginia Commonwealth University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   Immuron Ltd.
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: XR-NTX (Extended-Release Naltrexone);   Drug: Oral Naltrexone (O-NTX)
    Sponsor:   New York University School of Medicine
    Recruiting

  • Conditions:   Alcohol Dependence;   Post-Traumatic Stress Disorder (PTSD)
    Interventions:   Behavioral: Enhanced-Cognitive Processing Therapy-C (E-CPT-C);   Drug: Zonisamide;   Drug: Placebo
    Sponsors:   Yale University;   United States Department of Defense
    Recruiting

  • Condition:   Alcohol Dependence
    Interventions:   Drug: GET 73;   Drug: inactive ingredients capsule
    Sponsors:   Laboratorio Farmaceutico Ct S.r.l.;   Voisin Consulting, Inc.;   Latis Srl;   Quotient Bioresearch Ltd
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Conditions:   Hepatitis C;   Alcohol Abuse
    Interventions:   Other: Web-Based Brief Alcohol Intervention;   Other: Usual Care
    Sponsor:   VA Office of Research and Development
    Recruiting

  • Conditions:   Schizophrenia;   Cannabis Dependence;   Prodromal for Psychotic Illness;   Family History of Alcoholism
    Intervention:   Radiation: [11-C]OMAR
    Sponsors:   Yale University;   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH)
    Recruiting

  • Condition:   Alcohol Drinking
    Intervention:   Drug: Naltrexone
    Sponsor:   Yale University
    Recruiting

  • Conditions:   Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
    Interventions:   Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
    Sponsors:   Yale University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   VA Office of Research and Development
    Recruiting

  • Conditions:   Carcinoma, Hepatocellular;   Liver Cirrhosis, Alcoholic;   Hepatitis, Alcoholic;   Hepatitis, Chronic;   Hepatitis, Viral, Human
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Alcoholic Intoxication
    Interventions:   Drug: Alcohol;   Procedure: Self-Administration
    Sponsor:   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
    Recruiting